National Center for Complementary & Integrative Health; Notice of Closed Meeting, 12621-12622 [2017-04176]
Download as PDF
12621
Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices
CTSU AND NCI CIRB FORMS AND CTSU, CIRB AND CTEP SURVEYS—ESTIMATED ANNUALIZED BURDEN HOURS—
Continued
Average
burden per
response
(in hours)
Number of
responses per
respondent
Form name
Type of
respondent
Reviewer Worksheet Expedited Study Closure Review (Attachment B36).
Reviewer Worksheet Expedited Review of
Study Chair Response to CIRB-Required
Modifications (Attachment B37).
Reviewer Worksheet of Expedited IR (Attachment B38).
Reviewer Worksheet—CPC—Determination
of UP or SCN (Attachment B39).
Annual Signatory Institution Worksheet
About Local Context (Attachment B40).
Annual Principal Investigator Worksheet
About Local Context (Attachment B41).
Study-Specific Worksheet About Local Context (Attachment B42).
Study Closure or Transfer of Study Review
Responsibility Form (Attachment B43).
UP or SCN Reporting Form (Attachment
B44).
Change of SI PI Form (Attachment B45) .....
CTSU Website Customer Satisfaction Survey (Attachment C1).
CTSU Help Desk Customer Satisfaction
Survey (Attachment C2).
CTSU OPEN Survey (Attachment C3) .........
CIRB Customer Satisfaction Survey (Attachment C4) Satisfaction Survey (Attachment
C4).
Follow-up Survey (Communication Audit)
(Attachment C5).
Website Focus Groups, Communication
Project (Attachment C6 A–D).
CIRB Board Member Annual Assessment
Survey (Attachment C7).
PIO Customer Satisfaction Survey (Attachment C8).
Concept Clinical Trial Survey (Attachment
C9).
Prospective Clinical Trial Survey (Attachment C10).
Low Accrual Clinical Trial Survey (Attachment C11).
ETCTN PI Survey (Attachment 12) ..............
ETCTN RS Survey (Attachment 13) ............
Board Members ....................
20
1
15/60
5
Board Members ....................
5
1
30/60
3
Board Members ....................
5
1
30/60
3
Board Members ....................
40
1
15/60
10
Health Care Practitioner .......
400
1
40/60
267
Health Care Practitioner .......
1800
1
20/60
600
Health Care Practitioner .......
4800
1
20/60
1600
Health Care Practitioner .......
1680
1
15/60
420
Health Care Practitioner .......
360
1
20/60
120
Health Care Practitioner .......
Health Care Practitioner .......
120
275
1
1
15/60
15/60
30
69
Health Care Practitioner .......
325
1
15/60
81
Health Care Practitioner .......
Participants ...........................
60
600
1
1
15/60
15/60
15
150
Participants/Board Members
300
1
15/60
75
Participants/Board Members
18
1
1
18
Board Members ....................
60
1
20/60
20
Health Care Practitioner .......
60
1
5/60
5
Health Care Practitioner .......
500
1
5/60
42
Health Care Practitioner .......
1000
1
1/60
17
Health Care Practitioner .......
1000
1
1/60
17
Physician ..............................
Health Care Practitioner .......
75
175
1
1
15/60
15/60
19
44
Totals .....................................................
...............................................
24,100
100,337
........................
15,525
Dated: February 15, 2017.
Karla Bailey,
PRA OMB Liaison, Office of Management
Policy and Compliance, National Cancer
Institute (NCI) National Institutes of Health
(NIH).
Number of
respondents
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
[FR Doc. 2017–04253 Filed 3–3–17; 8:45 am]
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel, Exploratory Clinical
Trials and Studies of Natural Products.
Date: March 30, 2017.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Total annual
burden hours
VerDate Sep<11>2014
19:24 Mar 03, 2017
Jkt 241001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
E:\FR\FM\06MRN1.SGM
06MRN1
12622
Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Yisong Wang, Ph.D.,
Scientific Review Officer, NCCIH/NIH, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20817, 301–480–9483, yisong.wang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04176 Filed 3–3–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Quantitative Imaging for Evaluation of
Cancer Therapies (U01).
Date: March 29, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–5856, nadeem.khan@nih.gov.
CBPL No.
27–01
27–05
27–06
27–07
Dated: February 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
D
D
D
D
287
4928
473
4807
19:24 Mar 03, 2017
Notice of accreditation and
approval of Inspectorate America
Corporation as a commercial gauger and
laboratory.
ACTION:
Notice is hereby given,
pursuant to CBP regulations, that
Inspectorate America Corporation has
been approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes for the next three years as of
July 21, 2016.
DATES: The accreditation and approval
of Inspectorate America Corporation as
commercial gauger and laboratory
became effective on July 21, 2016. The
next triennial inspection date will be
scheduled for July 2019.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Inspectorate
America Corporation, 22934 Lockness
Ave, Torrance, CA 90501 has been
approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.12 and 19 CFR
151.13. Inspectorate America
Corporation is approved for the
following gauging procedures for
petroleum and certain petroleum
products from the American Petroleum
Institute (API):
SUMMARY:
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of
Inspectorate America Corporation, as a
Commercial Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
AGENCY:
API chapters
Title
3 .......................
7 .......................
8 .......................
12 .....................
17 .....................
[FR Doc. 2017–04173 Filed 3–3–17; 8:45 am]
ASTM
..............
..............
..............
..............
VerDate Sep<11>2014
Name of Committee: National Cancer
Institute Special Emphasis Panel, Digital
Platforms to Support Informal Cancer
Caregiving.
Date: March 30–31, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032/34, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Scott A. Chen, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W526, Bethesda, MD 20892–9750,
240–276–6038, chensc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Biomarkers and Biospecimens.
Date: March 31, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W106, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, MD 20892–
9750, 240–276–6384, gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Tank Gauging.
Temperature Determination.
Sampling.
Calculations.
Marine Measurement.
Inspectorate America Corporation is
accredited for the following laboratory
analysis procedures and methods for
petroleum and certain petroleum
products set forth by the U.S. Customs
and Border Protection Laboratory
Methods (CBPL) and American Society
for Testing and Materials (ASTM):
Title
Standard
Standard
Standard
Standard
Test
Test
Test
Test
Jkt 241001
Method
Method
Method
Method
PO 00000
for
for
for
for
API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method).
Water in Crude Oils by Coulometric Karl Fischer Titration.
Sediment in Crude Oils and Fuel Oils by the Extraction Method.
Sediment in Crude Oil by Membrane Filtration.
Frm 00090
Fmt 4703
Sfmt 4703
E:\FR\FM\06MRN1.SGM
06MRN1
Agencies
[Federal Register Volume 82, Number 42 (Monday, March 6, 2017)]
[Notices]
[Pages 12621-12622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04176]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Integrative Health Special Emphasis Panel, Exploratory Clinical
Trials and Studies of Natural Products.
Date: March 30, 2017.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy
[[Page 12622]]
Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Yisong Wang, Ph.D., Scientific Review Officer,
NCCIH/NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20817, 301-
480-9483, yisong.wang@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04176 Filed 3-3-17; 8:45 am]
BILLING CODE 4140-01-P